Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder

Cancer Treat Rep. 1984 May;68(5):793-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Altretamine / adverse effects
  • Altretamine / analogs & derivatives
  • Altretamine / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy
  • Drug Evaluation
  • Humans
  • Nausea / chemically induced
  • Random Allocation
  • Schistosomiasis / complications
  • Time Factors
  • Triazines / therapeutic use*
  • Urinary Bladder Neoplasms / complications
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Triazines
  • Altretamine
  • pentamethylmelamine